BioAge Labs, Inc. is a clinical-stage biopharmaceutical company specializing in the development ... BioAge announced that it discontinued its STRIDES Phase 2 trial for azelaprag, citing safety ...
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease ... The study was carried out in the Hans Popper Laboratory for Molecular ...